IV and Oral Iron Market
IV and Oral Iron Market

Global Intravenous (IV) Iron and Oral Iron Market – Strategic Assessment and Forecast Till 2021

$3,500.00$5,000.00

Global Intravenous (IV) Iron and Oral Iron Market By Mode of Delivery (Oral, Intravenous) By Therapeutic Area (Nephrology, Gynecology and Obstetrics, Gastroenterology, Oncology, Chronic heart failures, Patient Blood Management)  By Geography (APAC, America, EMEA) By Countries (Africa, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Netherland, New Zealand, Spain, Switzerland, UK, US) Industry Analysis, Market Size, Market Revenue, Market Share, Key Vendors, Growth, Trends, Drivers and Forecast 2017– 2021

Number of Pages: 94

Clear selection
StumbleUponEmail

Product Description

Global Intravenous (IV) Iron and Oral Iron Drugs market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%.

Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and intravenous (IV) iron therapy comes into the picture.

Global Intravenous (IV) Iron and Oral Iron market research report covers the present scenario and the growth prospects of the iron drugs market for the period 2016-2021. The report provides in-depth market analysis of market size and growth of Global Intravenous (IV) Iron and Oral Iron market.

Scope of the Report:

This market research report categories the Global Intravenous (IV) Iron and Oral Iron market based on mode of delivery, therapeutic area and geography. This market research includes a detailed market segmentation of the worldwide Intravenous (IV) iron and oral market by

By Mode of Delivery

  • Oral Iron
    • Ferrous Sulfate
    • Carbonyl Iron
  • Intravenous (IV) Iron
    • Iron Dextran Complex
    • Iron Sucrose
    • Ferric Carboxymaltose
By Therapeutic Area
  • Nephrology
  • Gynecology and Obstetrics
  • Gastroenterology
  • Oncology
  • Chronic Heart Failures
  • Patient Blood Management

By Geography

  • Americas
  • APAC
  • EMEA
By Country
  • Africa
  • Brazil
  • Canada
  • China
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Mexico
  • Netherland
  • New Zealand
  • Spain
  • Switzerland
  • UK
  • US

Global Intravenous (IV) Iron and Oral Iron Market – Market Size and Dynamics

Analysts at Beige Market Intelligence expects the global intravenous (IV) iron and oral iron market to cross US$ 3 billion by 2021, growing at an impressive CAGR close to 5%. Iron drugs are widely used in various therapeutic areas like nephrology, gynaecology, oncology, gastroenterology, surgeries, and chronic heart failures. This catalyses the growth of global intravenous (IV) iron and oral iron market. Furthermore, factors such as correction of IDA in pregnancy, growing diabetic population worldwide, growing incidence of Chronic Kidney Disease (CKD) that increases the need of dialysis, prevalence of iron deficiency are the major factors attributing to the growth of the market.

The global intravenous (IV) iron and oral iron market is majorly categorised into two categories as per there mode of delivery such as oral and intravenous (IV). The oral delivery of iron in form of tablets, capsules, syrups is the most economic medical treatment for iron deficiency anaemia. Ferrous sulfate is the most common and cheapest form of oral therapy for treating patients with iron deficiency anemia. Though oral iron drugs market size is expected to increase to a notable figure over next five years, it can lose significant amount of its market share to intravenous (IV) iron therapies in near future. Intravenously iron is delivered to patients who are either unable to absorb oral iron or who has increasing anemia despite adequate doses of oral iron. Growing incidence of Chronic Kidney Disease (CKD), iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology is driving growth of the intravenous iron therapy. The high growth rate of IV iron market can be attributed to the paradigm shift of healthcare providers/patients to IV iron therapies from oral iron therapies.

The research report provides a detailed analysis and growth forecast of each therapeutic area. Nephrology is the largest application area of the intravenous (IV) iron and oral iron drugs followed by Gynecology and Gastroenterology.

Global Intravenous (IV) Iron and Oral Iron – Trends, Drivers, and Challenges

The market research report on intravenous (IV) iron and oral iron market provides a comprehensive study about the factors affecting the market growth and upcoming challenges. The research report describes the growth driving factors of the global intravenous (IV) iron and oral iron market for the next five years. Increasing number of dialysis patients and growing diabetic population worldwide are among the major drivers described in the intravenous (IV) iron and oral iron market research report.

Paradigm shift from oral iron drugs to intravenous (IV) iron drugs is a major trend in the market. There are gastrointestinal side effects associated with oral iron drugs like nausea, constipation, anorexia, heartburn, vomiting, and diarrhea and are intolerant even by healthy patients. Thus the side effects of oral iron drugs has attracted the patients towards intravenous (IV) iron. Also with the increasing awareness of IDA during pregnancy and shift towards healthier lifestyle; correction of IDA in pregnant women is the current trend driving the market for oral and IV iron.

Today, the trend is driving towards focus on healthy diet, healthy lifestyle, adoption of healthy solutions to build health. Thus, intake of healthy diet and nutraceuticals is a blooming alternative for daily medication for nutrient deficiency like iron deficiency. Hence, focus on healthy diet and nutraceuticals is one of the major challenges included in the report

Global Intravenous (IV) Iron and Oral Iron – Key Market Growth Opportunities

The report outlines the major growth opportunities in global intravenous (IV) iron and oral iron market. It includes a detailed description of the opportunities for the year 2016-2021. Huge patient population undergoing dialysis and patient blood management are among the notable growth opportunities in the global intravenous (IV) iron and oral iron market. For patients suffering from severe anemia or hemorrhage, blood transfusions are proved to be life-saving. As the cost of blood transfusions is high, there are adverse outcomes of blood transfusion, and due to the questionable efficacy of transfusions the demand for patient blood management can be expected to rise; thus, opening arenas for iron therapies.

The report also provides the Porter’s five forces analysis along with a description of each of the forces and its impact on the market.

Global Intravenous (IV) Iron and Oral Iron – Geographical Analysis

The report includes the market analysis of global intravenous (IV) iron and oral iron market in different regions such as the Americas, APAC, and EMEA. The report outlines the major market share holder in the global intravenous (IV) iron and oral iron market and the market size analysis of all the regions. The intravenous (IV) iron and oral iron market report also provides the market size and forecast of the key countries. The America region is expected to be the largest market for intravenous (IV) iron and oral iron drugs followed by EMEA. US, Canada, and Brazil are the key countries in this region contributing a major chunk of revenue.

Large population of people suffering from CKD, diabetes and undergoing dialysis is going to spur the market for intravenous (IV) iron and oral iron in European nations. Likewise, in APAC region large population of people suffering from diabetes in major countries such as China, Japan, and India is going to propel the demand for intravenous (IV) iron and oral iron drugs. In addition, the increasing number of people undergoing renal replacement therapies in Australia and New Zealand, is expected to boost the market for intravenous (IV) iron and oral iron drugs.

Global Intravenous (IV) Iron and Oral Iron – Market Share and Key Vendors

This market research report profiles the major companies in the  global intravenous (IV) iron and oral iron drugs market and also provides the competitive landscape and indepth profile of key players.  Within the report covers the entire market outlook regarding the value chain operating within the market. The major players in the market include

  • Actavis
  • AMAG Pharmaceuticals
  • Cipla
  • Indoco Remedies
  • Vifor Pharma

The other leading vendors in the global intravenous (IV) iron and oral iron market include Sanofi, Arbro Pharmaceuticals, Solace Biotech, ALDE MEDI IMPEX, American Biocare.

Why Should you buy this report?

The report gives reasonable answers for the following questions which leads you to know the in- depth market analysis of market such as

  1. How has the market been performing and what are some of the current changes which are expected to change the landscape in the coming years?
  2. What are the various factors that can affect the market and in what way over the next few years?
  3. What are the emerging trends and challenges for the market over the next five years?
  4. What is the market size and market forecast for each market segment?
  5. What is the market size and market forecast for each user type?
  6. Which regions are going to have the largest market share and what are the factors propelling the market growth in that region?
  7. Which are the key countries and the market size and market forecast in the key countries?
  8. Which companies are the key vendors in the market?
  9. What are the strategies used by the top vendors, and what are the opportunities to grow?
  10. Which companies are the emerging vendors?

Intravenous (IV) and Oral Iron

Iron is one of the most important mineral in the human body that produces RBCs and carries oxygen throughout the body via the blood to get energy for all vital biological processes. 

Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and IV iron therapy comes into the picture.

Oral iron supplements (pills)

These are taken in by oral route (by mouth) in the form of pills.

Intravenous (IV) intake of iron

Intravenous (IV) intake of iron is delivering iron intravenously by infusion with a needle into a vein.

The key objectives of the study are as follows

To provide a detailed analysis of the worldwide IV and Oral Iron market

To provide a break-down of IV and Oral Iron market

By Mode of Delivery

By Therapeutic Area

By Geographic Segment

By Key Countries

By Vendors

To provide the competitive landscape of the key players operating in this market and how the market will evolve over the forecast period

To provide strategic insights into what is happening in the market and what should happen in the market during the forecast period

To provide key insights into the various factors that are aiding as well as adversely affecting the market and how this scenario will change during the forecast period

The scope of the study is as follows

The report provides the optimistic and pessimistic scenarios for IV and Oral Iron market.

the study considers the revenue generated by various Precision Agriculture vendors by geographic segments and key countries market share analysis:

  • America
  • APAC
  • EMEA

Timeline of the study is as follows

Base Year:               2015                      (Actual figures)

Forecast Period:     2016-2021          (Forecasted figures)

Why should you buy this study?

The study will tell the reader how the market has been performing over the last few years and how it is expected to perform over the next five years. Detailed analysis of the performance of the market is provided thereby providing the reader with key insights into what is taking place and how the market is being affected, both positively and adversely. Individuals who are interested in knowing which are the key companies involved in the market should purchase this report.

In short, the study will provide a holistic view of the Worldwide IV and Oral Iron Market, which are the companies that are involved in the market and what are the factors that contribute to this market. The report will also provide information on what are some of the trends that have started to surface and are expected to be a strong driving force in the market over the next five years.

 

 

 

Contents      
Section 1       Research Methodology
Section 2       Executive Summary
2.1        Key Market Facts
2.2       Geographical Scenario
2.3       Vendors in the Market
Section 3       Report Coverage
3.1        Scope of Study
3.2       Base Year
3.3       Assumptions
Section 4      Market Research Methodology
4.1       Geographical Segmentation
4.2       Vendor Segmentation
4.3       Currency Conversion Rates
Section 5       Introduction
5.1        Iron
5.2       Trivia about Iron Deficiency Anemia (IDA)
5.3       Iron Drugs
5.4       Population requiring intravenous iron supplementation
Section 6      Market Landscape
6.1       Market Overview
6.2       Vendors in the Market
Section 7       Key Excerpts of the Study
Section 8      Key Market Growth Drivers
8.1       Assessment of Market Growth Drivers
Section 9      Key Market Challenges
9.1       Assessment of Market Challenges
Section 10    Key Market Trends
Section 11     Key Market Growth Opportunity
Section 12     Evidence-based Research Studies
Section 13     Worldwide IV and Oral Iron Market, by Mode of Delivery
13.1      Oral Delivery of Iron
13.1.1    Ferrous sulfate
13.1.2   Carbonyl iron
13.2      Intravenous (IV) Delivery of Iron
13.2.1   Iron dextran Complex
13.2.2   Iron sucrose
13.2.3   Ferric carboxymaltose
Section 14     Worldwide IV and Oral Iron Market, by Therapeutic Area
14.1      Nephrology
14.2     Gynecology and Obstetrics
14.3     Gastroenterology
14.4     Oncology
14.5     Chronic Heart Failures
14.6     Patient Blood Management
Section 15     Worldwide IV and Oral Iron Market by Geography
Section 16     IV and Oral Iron Market in the Americas
16.1      Penetration of IV and Oral Iron Drugs in the Americas
16.1.1   Penetration of IV and Oral Iron Drugs in the US
16.1.2   Penetration of IV and Oral Iron Drugs in Canada
16.1.3   Penetration of IV and Oral Iron Drugs in Brazil
16.1.4   Penetration of IV and Oral Iron Drugs in Rest of the Americas
Section 17     IV and Oral Iron Market in EMEA
17.1      Penetration of IV and Oral Iron Drugs in EMEA
17.2      Penetration of IV and Oral Iron Drugs in Europe
17.2.1   Penetration of IV and Oral Iron Drugs in Germany
17.2.2   Penetration of IV and Oral Iron Drugs in the UK
17.2.3   Penetration of IV and Oral Iron Drugs in France
17.2.4  Penetration of IV and Oral Iron Drugs in Italy
17.2.5   Penetration of IV and Oral Iron Drugs in Spain
17.2.6  Penetration of IV and Oral Iron Drugs in RoE
17.3      Penetration of IV and Oral Iron Drugs in the Middle East
17.4     Penetration of IV and Oral Iron Drugs in Africa
Section 18     Penetration of IV and Oral Iron Drugs in APAC
18.1      Penetration of IV and Oral Iron Drugs in APAC
18.1.1   Penetration of IV and Oral Iron Drugs in Japan
18.1.2   Penetration of IV and Oral Iron Drugs in China
18.1.3   Penetration of IV and Oral Iron Drugs in India
18.1.4   Penetration of IV and Oral Iron Drugs in Rest of APAC (RoAPAC)
Section 19     Market Share Analysis
19.1      Market Share Analysis
19.2     Vifor Pharma
19.3     Actavis, Inc.
19.4     AMAG Pharmaceuticals, Inc.
19.5     Sanofi
19.6     Indoco Remedies Ltd.
19.7     Cipla Limited
19.8     Arbro Pharmaceuticals Limited
19.9     Solace Biotech
19.10    ALDE MEDI IMPEX LTD.
19.11    American Biocare
Section 20    Key Vendor Analysis
20.1    Vifor Pharma Ltd
20.1.1   About the Company
20.1.2  Product Offerings
20.1.3  Strengths
20.1.4  Opportunity
20.2    AMAG Pharmaceuticals, Inc.
20.2.1  About the Company
20.2.2  Product Offerings
20.2.3  Strength
20.2.4  Weakness
20.3    Actavis Pharma, Inc.
20.3.1  About the Company
20.3.2  Product Offerings
20.3.3  Strengths
20.3.4  Weaknesses
20.4   Indoco Remedies Ltd.
20.4.1  About the Company
20.4.2  Product Offerings
20.4.3  Strengths
20.4.4 Opportunities
20.5    Cipla Limited
20.5.1  About the Company
20.5.2  Product Offerings
20.5.3  Strengths
20.5.4  Weakness
Section 21     Summary of the Report
Section 22    Appendix
22.1      List of Abbreviations
 
Exhibits       
Exhibit 1          Segmentation of IV and Oral Iron Market
Exhibit 2         Market Size Calculation – Bottom-up Approach
Exhibit 3         Market Size Calculation – Top-down Approach
Exhibit 4         Currency Conversion Chart
Exhibit 5         Worldwide IV and Oral Iron Market2015-2021 (US$ Million)
Exhibit 6         Diabetic Population across Geographies, 2015 and 2040 (estimated)
Exhibit 7         Assessment of Market Growth Drivers
Exhibit 8         ESAs in the pipeline
Exhibit 9         Assessment of Market Challenges
Exhibit 10        Number of Dialysis Patients Worldwide, Forecast to 2020
Exhibit 11        Evidence-based Research Studies for IV and Oral Iron Drugs
Exhibit 12        Global IV and Oral Iron Market Share, by Mode of Delivery (2015)
Exhibit 13        Global Oral Iron Market 2015 to 2021 (US$ Million)
Exhibit 14        Global Intravenous (IV) Iron Market 2015 to 2021 (US$ Million)
Exhibit 15        Global IV and Oral Iron Market, by Therapeutic Area (2015)
Exhibit 16        Global IV and Oral Iron Market in Nephrology, 2015 to 2021 (US$ Million)
Exhibit 17        Prevalence of Anemia in Women 15-49 years of age, 2015
Exhibit 18        Global IV and Oral Iron Market in Gynecology and Obstetrics, 2015 to 2021 (US$ Million)
Exhibit 19        Estimate of Bariatric Surgery Numbers in the US (2011-2015)
Exhibit 20       Global IV and Oral Iron Market in Gastroenterology, 2015 to 2021 (US$ Million)
Exhibit 21        Global IV and Oral Iron Market in Oncology, 2015 to 2021 (US$ Million)
Exhibit 22       Global IV and Oral Iron Market in Chronic Heart Failures, 2015 to 2021 (US$ Million)
Exhibit 23       Global IV and Oral Iron Market in Patient Blood Management, 2015 to 2021 (US$ Million)
Exhibit 24       Worldwide IV and Oral Iron Market by Geography (2015)
Exhibit 25       IV and Oral Iron Market in the Americas 2015 to 2021 (US$ Million)
Exhibit 26       IV and Oral Iron Market in Americas Market Share by Country (2015)
Exhibit 27       IV and Oral Iron Market in the US 2015-2021 (US$ Million)
Exhibit 28       IV and Oral Iron Market in Canada 2015-2021 (US$ Million)
Exhibit 29       IV and Oral Iron Market in Brazil 2015-2021 (US$ Million)
Exhibit 30       Diabetes in Mexico, 2015
Exhibit 31        IV and Oral Iron Market in Rest of the Americas 2015-2021 (US$ Million)
Exhibit 32       IV and Oral Iron Market in EMEA 2015-2021 (US$ Million)
Exhibit 33       IV and Oral Iron Market in EMEA Market Share by Region (2015)
Exhibit 34       IV and Oral Iron Market in Europe 2015-2021 (US$ Million)
Exhibit 35       Number of ESRD patients by therapy, European Union
Exhibit 36       IV and Oral Iron Market in Europe by Market Share in EU5 Countries (2015)
Exhibit 37       Diabetes in Germany, 2015
Exhibit 38       IV and Oral Iron Market in Germany 2015-2021 (US$ Million)
Exhibit 39       People having diabetes in the UK, 2016
Exhibit 40       The price differential between OFP and IV therapies (drug cost only)
Exhibit 41        IV and Oral Iron Market in the UK 2015 to 2021 (US$ Million)
Exhibit 42       Diabetes in France, 2015
Exhibit 43       IV and Oral Iron Market in France 2015-2021 (US$ Million)
Exhibit 44       Diabetes in Italy, 2015
Exhibit 45       IV and Oral Iron Market in Italy 2015-2021 (US$ Million)
Exhibit 46       Diabetes in Spain, 2015
Exhibit 47       IV and Oral Iron Market in Spain 2015 to 2021 (US$ Million)
Exhibit 48       Diabetes in the Netherlands, 2015
Exhibit 49       Diabetes in Sweden, 2015
Exhibit 50       Diabetes in Switzerland, 2015
Exhibit 51        IV and Oral Iron Market in RoE 2015-2021 (US$ Million)
Exhibit 52       IV and Oral Iron Market in the Middle East 2015-2021 (US$ Million)
Exhibit 53       IV and Oral Iron Market in Africa 2015-2021 (US$ Million)
Exhibit 54       IV and Oral Iron Market in APAC 2015-2021 (US$ Million)
Exhibit 55       IV and Oral Iron Market in APAC, Market Share by Country (205)
Exhibit 56       Diabetes in Japan, 2015
Exhibit 57       IV and Oral Iron Market in Japan 2015-2021 (US$ Million)
Exhibit 58       Diabetes in China, 2015
Exhibit 59       IV and Oral Iron Market in China 2015-2021 (US$ Million)
Exhibit 60       IV and Oral Iron Market in India 2015-2021 (US$ Million)
Exhibit 61        Prevalence (pmp) of Renal Replacement Therapy, 1995 to 2014
Exhibit 62       Prevalence (pmp) of Renal Replacement Therapy by Age 2014
Exhibit 63       Diabetes in Republic of Korea, 2015
Exhibit 64       IV and Oral Iron Market in RoAPAC 2015-2021 (US$ Million)
Exhibit 65       Market Share of Vifor Pharma in IV and Oral Iron, 2015
Exhibit 66       Market Share of Vifor Pharma in Oral Iron, 2015
Exhibit 67       Market Share of Vifor Pharma in Intravenous (IV) Iron, 2015
Exhibit 68       Descriptive Summary of Worldwide IV and Oral Iron Market
Exhibit 69       Summary of worldwide IV and Oral Iron Market by Mode of Delivery 2015-2021 (US$ Million)
Exhibit 70       Summary of worldwide IV and Oral Iron Market by Therapeutic Area 2015-2021 (US$ Million)
Exhibit 71        Summary of worldwide IV and Oral Iron Market by Geography 2015-2021 (US$ Million)
Exhibit 72       Summary of IV and Oral Iron Market in Americas by Country 2015-2021 (US$ Million)
Exhibit 73       Summary of IV and Oral Iron Market in EMEA by Country 2015-2021 (US$ Million)
Exhibit 74       Summary of IV and Oral Iron Market in Asia-Pacific (APAC) by Country 2015-2021 (US$ Million)
           





Reviews

There are no reviews yet.

Be the first to review “Global Intravenous (IV) Iron and Oral Iron Market – Strategic Assessment and Forecast Till 2021”

Additional Information

License Type

Single User, Team User, Enterprise User

Request Call Back
Request Call Back
Need Custom Report?
click here

Our Services

  • Beige Market Intelligence - Syndicated Research Reports

  • Beige Market Intelligence - Market Research and Custom Research

  • Beige Market Intelligence - Business Consulting